Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Medicinal Chemicals & Botanical Products

Curaleaf Holdings, Inc. to acquire Aurora Cannabis Inc

Announced Oct 5, 2026 · Announced

Deal value—
Premium86.0%To unaffected price
EV / Adj. EBITDA—
ConsiderationCash and stock$5.00 per share

Transaction

Acquirer
Curaleaf Holdings, Inc. (CURA)
Target
Aurora Cannabis Inc (ACB)
Buyer type
Strategic
Offer price per share
$5.00
Enterprise value
—
Status
Announced

Deal protections

Not yet read from the merger agreement.

Advisors

To the acquirer
Not disclosed
To the target
Not disclosed

Sector context · Healthcare

Comparable deals
106 in the prior 24 months
Premium
86.0% vs. 44.5% sector median
EV / Adj. EBITDA
Sector median 10.7x
Break fee
Sector median 3.5%

Timeline

  1. AnnouncedOct 5, 2026
  2. ClosedPending
Sources
  • 8-K (EX-99.2) · Oct 6, 2026
  • 425 (EX-99.2) · Oct 6, 2026

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.